Related Experiment Video
Updated: Sep 27, 2025

The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
[Sexual side effects from treatment with SSRI]
Cecilie Lybeck Hutters1, Annamaria Giraldi1,2
1Sexologisk Klinik, Psykiatrisk Center København, Rigshospitalet.
Selective serotonin reuptake inhibitors (SSRIs) frequently cause sexual dysfunction. Management strategies involve dose changes or medication alternatives, with some patients experiencing persistent post-SSRI sexual issues.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed antidepressants.
- Sexual dysfunction is a common and distressing side effect of SSRI treatment.
- The underlying mechanism is linked to serotonergic pathways affecting sexual response.
Purpose of the Study:
- To review the incidence and mechanisms of SSRI-induced sexual dysfunction.
- To discuss management strategies for patients experiencing these side effects.
- To highlight the phenomenon of persistent post-SSRI sexual dysfunction.
Main Methods:
- Literature review of studies on SSRI treatment and sexual side effects.
- Analysis of reported frequencies of sexual dysfunction with different SSRIs.
- Examination of proposed management approaches and persistent dysfunction.
Main Results:
- High incidence (over 70%) of sexual dysfunction reported with sertraline, citalopram, and paroxetine.
- Escitalopram and fluvoxamine appear to have a lower propensity for causing sexual dysfunction.
- Persistent sexual dysfunction after SSRI cessation (post-SSRI sexual dysfunction) is noted in a subset of patients.
Conclusions:
- SSRI-induced sexual dysfunction is prevalent and requires clinical attention.
- Strategies like dose reduction, switching SSRIs, or add-on therapies can manage side effects.
- Awareness of persistent post-SSRI sexual dysfunction is crucial for patient care.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

